Xencor (XNCR) Non Operating Income (2013 - 2026)
Xencor (XNCR) reported Non Operating Income of $396000.0 for Q1 2026, up 1377.42% year-over-year from $26803.5 in Q1 2025, and down 99.55% quarter-over-quarter from $87.9 million in Q4 2025.
Xencor (XNCR) Non Operating Income (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Non Operating Income data on file, last reported at $396000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $396000.0, up 1377.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $88.3 million (up 256.15% YoY), and the FY2025 annual result was $87.9 million, up 255.48% from the prior year.
- Non Operating Income fell to $396000.0 in Q1 2026 per XNCR's latest filing, from $87.9 million in the prior quarter.
- Over five years, Non Operating Income peaked at $87.9 million in Q4 2025 and troughed at -$56.5 million in Q4 2024.
- A 5-year average of $1.3 million and a median of -$10000.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income jumped 2850.34% in 2023, then tumbled 102284.21% in 2024.
- A 5-year view of Non Operating Income shows it stood at $1.9 million in 2022, then soared by 76.39% to $3.3 million in 2023, then sank by 1799.28% to -$56.5 million in 2024, then surged by 255.63% to $87.9 million in 2025, then tumbled by 99.55% to $396000.0 in 2026.
- Business Quant data shows XNCR's Non Operating Income at $396000.0 in Q1 2026, $87.9 million in Q4 2025, and -$17000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 396,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 396,000.00 |
| Dec 31, 2025 | 87.93 Mn |
| Sep 30, 2025 | -17,000.00 |
| Jun 30, 2025 | -17,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Dec 31, 2024 | -56.50 Mn |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -19.45 Mn |
| Dec 31, 2023 | 3.33 Mn |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 4.04 Mn |
| Mar 31, 2023 | -19,000.00 |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -147,000.00 |
| Mar 31, 2022 | -96,000.00 |
| Dec 31, 2021 | -58.73 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | -6,000.00 |